ArticleMediators of inflammation2026
Cytokine and Oxylipin Production in Resting and LPS-Stimulated Monocytes From Americans of African Ancestry Are Influenced by ALOX5 Promoter Tandem Repeat Polymorphisms.
Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The arachidonate 5-lipoxygenase (ALOX5) specificity protein 1 (Sp1) promoter tandem repeat polymorphism is associated with enhanced cardiovascular disease (CVD) risk. However, a functional understanding of these variants in immune cells central to disease development remains limited. We investigated oxylipin and cytokine production in resting and lipopolysaccharide (LPS)-stimulated CD14+ monocytes from individuals carrying promoter variants and common alleles of ALOX5. Compared to monocytes from subjects carrying two common five-repeat alleles (55 genotype), resting monocytes from individuals carrying one or more ALOX5 deletion (d) alleles (d5 and dd genotypes) produced increased levels of IL-1β, IL-6, TNF-ɑ, and IL-10 but lower quantities of putative trihydroxyeicosapenataenoic acid (TriHEPE) isomers detected with the same mass transition as resolvin E1 (RvE1) but slightly longer retention times. With the common 55 genotype, TriHEPEs increased as IL-6, IL-10, and TNF-ɑ production increased. This positive relationship between TriHEPEs and cytokines was diminished in monocytes with truncated ALOX5 alleles. In response to LPS, monocytes from individuals with d5 and dd genotypes produced higher levels of IL-1β, IL-6, and TNF-ɑ but not IL-10, as well as increased quantities of cyclooxygenase (COX) products 11-hydroxyeicosatetraenoic acid (11-HETE), prostaglandin E2 (PGE
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.